Calcitonin gene-related peptide and other neuropeptides in the plasma of patients with soft tissue injury

Abstract

Calcitonin gene-related peptide [CGRP] — a powerful vasodilator, is a 37 amino acid peptide that is find primarily in the central and peripheral nervous system. It affects the regulation of local blood flow, smooth muscle tone and glandular secretion. It is an endocrine regulator and in the lungs it also exerts a bronchoconstricting effect. CGRP has a proliferative effect on human endothelial cells. Therefore, it is important for the formation of new vessels, example, in ischemia, inflammations, and in the healing of wounds. Plasma levels of CGRP are increase in patients with chronic cardiac failure and sepsis, indicating that CGRP may be another important peptide in chronic illness. We have therefore measured the release of this peptide and another sensory peptide [Substance P (SP)]; a vasoconstrictor peptide [Endothelin (ET)]; and a perivascular peptide [Neuropeptide Y (NPY)], within 24 hours of injury, in the plasma of patients with soft tissue injury. Neuropeptides were measure by enzyme immunoassay technique. Median:(lowerquartile-upperquartile) in pmol/L CGRP level was elevated in patients [50.37 : (12.4–110.9)] compared to controls [13.9 : (10.9–36.96)] p < 0.05; Endothelin and NPY did not vary much between groups p = NS; ET: patients [8.7 : (1.7–87.1), controls 8.8 : (1.7–32.9)]; NPY: Patients [11.7 : (10.5–14.99), controls 11 : (10.3–12.8)]. SP was increase in patients [302.3 : (79.9–707.3)], than controls [5.6 : (3.2–36.6)] p < 0.05. Furthermore, Elastase (a decisive marker for inflammation and infectious complications), was measure (ng/L), and found to be slightly higher in patients (102:25.5–223), than controls (91.8:45.9–127). In summary, plasma levels of sensory peptides increased significantly, in patients with soft tissue injury, in contrast to vasocostrictor peptides that remained unchanged. These sensory peptides may yet be another group of neuromodulators playing a significant role in immune, pain, inflammatory and wound healing in soft tissue injury patients.